Evidence map›Paper›PMID 41152283›Full record

Trial reportScientific reports2025

A randomized trial on the feasibility of high-intensity interval training during chemotherapy in young breast cancer patients.

Maciej Górecki, Joanna Kufel-Grabowska, Magdalena Dudek, Maria Litwiniuk, Alicja Nowak, Agnieszka Bartczak-Rutkowska, Ewa Straburzyńska-Migaj, Janusz Doś, Andrzej Marszałek, Piotr Nowaczyk and 5 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06190600 (Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06190600 naactive not recruitingnot on this map

Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy

TypeinterventionalSponsorThe Greater Poland Cancer CentreRan2018 to 2026Enrolled40ConditionsBreast CancerArmsHigh Intensity Interval Training (HIIT), neoadjuvant treatment (doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, pertuzumab), Standard Supportive Care
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maciej GóreckiDepartment of Oncological Physiotherapy, Greater Poland Cancer Centre, Poznan, Poland.
Joanna Kufel-GrabowskaDepartment of Oncology and Radiotherapy, Medical University of Gdansk, Gdańsk, Poland.
Magdalena Dudek1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Maria LitwiniukDepartment of Physiotherapy, University School of Physical Education, Poznan, Poland.
Alicja Nowak1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Agnieszka Bartczak-Rutkowska1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Ewa Straburzyńska-Migaj1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Janusz DośDepartment of Oncological Physiotherapy, Greater Poland Cancer Centre, Poznan, Poland.
Andrzej MarszałekDepartment of Oncologic Pathology and Prophylaxis, Poznan University of Medical Sciences and Greater Poland Cancer Centre, Poznan, Poland.
Piotr NowaczykBreast Surgical Oncology Department, Greater Poland Cancer Centre, Poznan, Poland.
Marta LembrykDepartment of Oncological Physiotherapy, Greater Poland Cancer Centre, Poznan, Poland.
Igor PiotrowskiRadiobiology Lab, Department of Medical Physics, Greater Poland Cancer Centre, Poznan, Poland. igor.piotrowski@wco.pl.
Wiktoria SuchorskaRadiobiology Lab, Department of Medical Physics, Greater Poland Cancer Centre, Poznan, Poland.
Maciej Lesiak1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Sławomir MarszałekDepartment of Oncological Physiotherapy, Greater Poland Cancer Centre, Poznan, Poland.

Funding

Greater Poland Cancer Centre 22/02/2019/F/WCO/0014
6 · The paper itself

Abstract

Chemotherapy used to treat breast cancer (BC) in young women often results in significant side effects, among others myelotoxicity, nausea, neurotoxicity, ataxia, and fatigue. These negative effects can be offset by physical activity employed concurrently with the treatment. One of the training modalities - high-intensity interval training (HIIT) - has been the subject of many studies showing significant health benefits, with the advantage of being time-efficient. The aim of this study was to investigate whether HIIT can be successfully employed for young BC patients undergoing chemotherapy. Forty young (18-40 years old) BC patients scheduled for chemotherapy were randomized to undergo supervised HIIT concurrently with chemotherapy or instructed to perform World Health Organization-recommended volume of daily physical activity (control group). Measurements included retention, adherence to training, and body composition parameters (BMI, muscle mass, fat mass, handgrip strength on affected and unaffected side) measured before and after therapy. HIIT scheduled concurrently with chemotherapy was a feasible approach for young BC patients (retention: 94.74%, adherence: 100%). Employment of HIIT also resulted in higher handgrip strength compared to no supervised training (1.2 kg between-group difference). This study shows that HIIT introduced and conducted along the chemotherapy is feasible for young BC patients. This approach can offset the negative effects of chemotherapy on physical fitness.Trial registrationThe study was registered in the clinicaltrials.gov registry (#NCT06190600) on 05/01/2024, retrospectively registered.

Indexed as

Breast NeoplasmsHigh-Intensity Interval TrainingAdolescentAdultBody CompositionFeasibility StudiesFemaleHand StrengthHumansYoung AdultBody compositionBreast cancerChemotherapyHigh-intensity interval trainingPhysiotherapy

Identifiers

PMID41152283
PMCPMC12569209

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.